SARS-CoV-2—The Autoimmune Virus Is Still Striking

Editorial SARS-CoV-2—The Autoimmune Virus Is Still Striking Naim Mahroum 1,* and Yehuda Shoenfeld 2,3 1 International School of Medicine, Istanbul Medipol University, Kavacık, Göztepe Mah, Atatürk Cd. No:40, Beykoz, Istanbul 34810, Turkey 2 Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel 3 Reichman University, Herzliya 4610101, Israel * Correspondence: [email protected]; Tel.: +90-216-681-5100; Fax: +90-212-531-7555 Received: 27 November 2024; Accepted: 29 November 2024; Published: 2 December 2024 Abstract: While the pandemic of COVID-19 has ended according to the WHO, new emerging cases are still documented worldwide. In addition, due to the huge number of recovered individuals, the sequelae of COVID-19 constitute a real challenge for the medical community. Of importance, is the autoimmune-nature of SARS-CoV-2. Hereby, in our editorial we aimed to shed light over the autoimmune aspects of COVID-19. Understanding the aspects presented aid in the early detection and management of affected patients.